Anti-Profiteering Body Put Patanjali Under Scanner

Anti-profiteering body investigating the Baba Ramdev’s Patanjali Ayurveda on the behalf of a complaint registered alleging that the Patanjali made profits with selling consumer goods like cosmetics, toothpaste, shampoo etc but not passed the GST rate cut benefits announced by the GST Council meeting in November 2017. Anti-profiteering (DG-AP) investigating the issue and scanning Patanjali records.
National Anti-profiteering Authority under GST has been set up by the Narendra Modi government to secure users’ interest and to ensure that companies pass the tax cut benefits to them.

A similar complaint was registered against FMCG firm Hindustan Unilever in January 2018 and the Directorate General of Safeguards (DGS) of the anti-profiteering body investigating the issue and took three of extension to scan company accounts. DGS mandates to finish and submit reports of investigation in three months under the anti-profiteering rules but can get extensions.

An extension has been approved as the process is time-consuming and DGS asked Hindustan Unilever Limited to submit about the prices of its entire range of products pre and post GST rate cut in November 2017. GST Council rationalized GST rates on more than 200 items on November 11, 2017, and the most of items were consumer goods.

There are some other cases as well like in April 2017 DGS sent notice to Jubilant FoodWorks to share their tax cut benefits on their restaurant services from 18% to 5% were passed to customers or not at its Dominos Pizza outlet. Brands like McDonald’s franchisees, Retail shopping outlet, Lifestyle International and a Honda Car dealer have also received notices for not passing GST benefit to the consumers.
According to the last available reports, Patanjali Ayurveda reported a 53.7% hike in its net revenue of Rs 1,193.8 crore in the year ended March 2017. In January 2018 Patanjali declared that the company is partnering with big e-commerce brands such as Amazon and Flipkart to sell Patanjali products online and hoping to double its revenue to about Rs 20,000 crore by next year.

Related Posts

MedTech Zone AMTZ Puts Vizag on the Science Map of India

Vizag Science &Technology Cluster rated as one of the India’s Strategic Innovation Hubs Visakhapatnam, June 28 – In a significant boost to Vizag’s growing scientific stature, the Andhra Pradesh MedTech…

  • Health
  • June 11, 2025
  • 382 views
Doctors trialling ‘poo pills’ to flush out dangerous superbugs

UK doctors are attempting to clear dangerous superbug infections using “poo pills” containing freeze-dried faeces. The stool samples come from healthy donors and are packed with good bacteria. Early data…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

MedTech Zone AMTZ Puts Vizag on the Science Map of India

MedTech Zone AMTZ Puts Vizag on the Science Map of India

Bharat Biotech, GSK to cut malaria vaccine price by more than half by 2028

Bharat Biotech, GSK to cut malaria vaccine price by more than half by 2028

Sun Pharma ropes in Richard Ascroft as North America CEO

Sun Pharma ropes in Richard Ascroft as North America CEO

Torrent Pharma shares surge 4% as JPMorgan upgrades to overweight; 18% upside seen

Torrent Pharma shares surge 4% as JPMorgan upgrades to overweight; 18% upside seen